Erratum: Long-Term Probucol Treatment Prevents Secondary Cardiovascular Events: a Cohort Study of Patients with Heterozygous Familial Hypercholesterolemia in Japan [Journal of Atherosclerosis and Thrombosis 1506 292-303]

Shizuya Yamashita; Hideaki Bujo; Hidenori Arai; Mariko Harada-Shiba; Shigeyuki Matsui; Masanori Fukushima; Yasushi Saito; Toru Kita; Yuji Matsuzawa

doi:10.5551/jat.E16-1

Erratum

Erratum: Long-Term Probucol Treatment Prevents Secondary Cardiovascular Events: a Cohort Study of Patients with Heterozygous Familial Hypercholesterolemia in Japan [Journal of Atherosclerosis and Thrombosis 1506 292-303]

Shizuya Yamashita, Hideaki Bujo, Hidenori Arai, Mariko Harada-Shiba, Shigeyuki Matsui, Masanori Fukushima, Yasushi Saito, Toru Kita, Yuji Matsuzawa

Author information

Shizuya Yamashita
Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine.
Hideaki Bujo
Department of Genome Research and Clinical Application, Chiba University Graduate School of Medicine.
Hidenori Arai
Department of Geriatric Medicine, Kyoto University Graduate School of Medicine.
Mariko Harada-Shiba
Department of Bioscience, National Cardiovascular Center Research Institute.
Shigeyuki Matsui
Department of Pharmacoepidemiology, School of Public Health, Kyoto University.
Masanori Fukushima
Translational Research Center, Kyoto University Hospital, Kyoto University Graduate School of Medicine.
Yasushi Saito
Department of Clinical Cell Biology, Chiba University Graduate School of Medicine.
Toru Kita
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine.
Yuji Matsuzawa
Department of Internal Medicine, Sumitomo Hospital.